Shrinking birthmarks: bleomycin injections show promise for cystic hygromas in kids
NCT ID NCT07189832
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested injecting bleomycin directly into cystic hygromas (fluid-filled birthmarks) in 30 children aged 1 month to 12 years. The fluid was drained and bleomycin injected, repeated every 4 weeks until the lump shrank. Most children saw significant size reduction, with some having complete shrinkage. This offers a potential alternative to surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bleomycin
- What this could lead to
- If successful, this approach could offer a non-surgical way to shrink cystic hygromas in children, reducing the need for more invasive procedures.
- What could go wrong
- This is a small, completed study with no control group, so results may not apply to all patients. Bleomycin can cause side effects like skin changes or lung issues, though rare with local injection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHATIC MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University Specialized Pediatric Hospital (Abu EL-Reesh hospital)
Cairo, Cairo Governorate, 12613, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.